Laurence Harbige
11Patents
3h-index
6Co-inventors
49Inventor score
Filing activity: May 14, 2004 → Jul 5, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7935729B2 | Use of triglyceride oils containing γ-linolenic acid residues and linoleic acid residues for the treatment of neurodegenerative disease | Human Necessities | 17 | Active |
| US8748600B2 | Cyclic triazo sodium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US8691818B2 | Cyclic triazo and diazo sodium channel blockers | Emerging Cross-Sectional Technologies | 4 | Active |
| US8748599B2 | Cyclic triazo sodium channel blockers | Emerging Cross-Sectional Technologies | 3 | Active |
| US8268823B2 | Medical use of triazine derivatives | Emerging Cross-Sectional Technologies | 3 | Active |
| US9000155B2 | Cyclic triazo sodium channel blockers | Emerging Cross-Sectional Technologies | 2 | Active |
| US9422253B2 | Cyclic triazo and diazo sodium channel blockers | Emerging Cross-Sectional Technologies | 1 | Active |
| US9862691B2 | Cyclic triazo and diazo sodium channel blockers | Emerging Cross-Sectional Technologies | 1 | Active |
| US7964641B2 | Treatment of neurodegenerative conditions | Chemistry; Metallurgy | 0 | Active |
| US8114903B2 | Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids | Chemistry; Metallurgy | 0 | Active |
| US10576086B2 | Triazine derivatives as interferon-gamma inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.